Sonoma Pharmaceuticals, Inc. (SNOA)
3.29
+0.02
(+0.61%)
USD |
NASDAQ |
Jan 16, 16:00
3.31
+0.02
(+0.61%)
After-Hours: 20:00
Sonoma Pharmaceuticals EPS Diluted (Quarterly): -0.3244 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
| NanoViricides, Inc. | -0.1045 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.534M |
| Revenue (Quarterly) | 5.604M |
| Total Expenses (Quarterly) | 6.138M |
| Enterprise Value | 3.097M |
| Gross Profit Margin (Quarterly) | 37.83% |
| Profit Margin (Quarterly) | -9.53% |
| Earnings Yield | -66.68% |
| Normalized Earnings Yield | -66.68 |